x
- Industry: Business Research
- Study Type: Zevicefta and Disease Profile (cIAI, cUTI & HAP|VAP) Study
- Client: A Leading Pharmaceutical Company
Background & Key Objectives
- Landscape report on Hospital & Ventilator Acquired Pneumonia (HAP|VAP), Complicated Urinary track infection (cUTI)|Pyelonephritis and Complicated Intra-Abdominal Infection (cIAI).
- Detailed profile on Zavicefta (Ceftazidime-avibactam) for USA and EU.
Methodology & Approach
- Performed an exhaustive desk research on the Zavicefta and Hospital & Ventilator Acquired Pneumonia (HAP|VAP), Complicated Urinary track infection (cUTI)|Pyelonephritis and Complicated Intra-Abdominal Infection (cIAI).
- Referred multiple sources like USA FDA, EMEA, Orange book, clincialtrials.gov, CDC, and others along with open search
- Zevicefta profile
- Overview, chemical structure, dosage and administration, clinical updates, sales, investments, regulatory updates, etc. .
- The study aimed to gather deep information on the diseases like cIAI, cUTI & HAP, where our team presented an overview of these diseases, its risk factors, symptoms, diagnosis, treatment strategy & algorithm, economic burden, etc.
- Pipeline analysis on investigational agents in Phase 2/3
- Comparative assessment of existing brands
Our Solution
- The study helped the end client to make tweaks in the sales and marketing of their existing products.
- Also, this desk research study aided the client to develop and launch a new and more effective drug for these diseases.
- Final report in PPT format (135 slides)